LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 76.02 | 771.67 | 6913 | 11106 | 0.6224 | 0.7681 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 78.25 | 771.67 | 10980 | 11367 | 0.9659 | 0.9822 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 78.25 | 771.67 | 7003 | 11367 | 0.6160 | 0.7653 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 80.48 | 771.67 | 11197 | 11685 | 0.9582 | 0.9784 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 80.48 | 771.67 | 7113 | 11685 | 0.6087 | 0.7622 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 82.69 | 771.67 | 11442 | 11974 | 0.9556 | 0.9772 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 82.69 | 771.67 | 7129 | 11974 | 0.5954 | 0.7543 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 84.92 | 771.67 | 11760 | 12266 | 0.9587 | 0.9790 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 84.92 | 771.67 | 7052 | 12266 | 0.5749 | 0.7409 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 87.14 | 771.67 | 11881 | 12592 | 0.9435 | 0.9713 | MN20160304_L01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 87.14 | 771.67 | 7176 | 12592 | 0.5699 | 0.7394 | MN20160304_L01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 2.49 | 771.67 | 835 | 867 | 0.9623 | 0.5935 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 2.49 | 771.67 | 749 | 867 | 0.8632 | -0.1615 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 4.71 | 771.67 | 921 | 956 | 0.9630 | 0.7708 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 4.71 | 771.67 | 863 | 956 | 0.9024 | 0.4352 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 6.94 | 771.67 | 991 | 1045 | 0.9482 | 0.7712 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 6.94 | 771.67 | 952 | 1045 | 0.9109 | 0.6159 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 9.16 | 771.67 | 1077 | 1138 | 0.9460 | 0.8115 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 9.16 | 771.67 | 1026 | 1138 | 0.9012 | 0.6615 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 11.56 | 771.67 | 1193 | 1280 | 0.9316 | 0.8151 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 11.56 | 771.67 | 1172 | 1280 | 0.9152 | 0.7716 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 13.78 | 771.67 | 1298 | 1459 | 0.8892 | 0.7602 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 13.78 | 771.67 | 1254 | 1459 | 0.8591 | 0.6955 | MN20160304_L01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 16.00 | 771.67 | 1404 | 1585 | 0.8855 | 0.7791 | MN20160304_L01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 16.00 | 771.67 | 1337 | 1585 | 0.8433 | 0.6973 | MN20160304_L01 | E11 |